Prevalence of joint complaints amongst individuals with Dupuytren's disease - From the Reykjavik study

Scandinavian Journal of Rheumatology

Volumn 28, Issue 5, 1999, Pages 300-304

  Guomundsson, K G ^c   Arngrimsson R ^c   Sigfusson N ^a   Jónsson, Thorbjörn ^b  

^a Heart Preventive Clinic Reykjavik   (Iceland)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c NONE

Author keywords

Autoantibodies; Dupuytren's contracture; Rheumatic diseases; Rheumatoid factor

Indexed keywords

ADULT; AGED; ARTHRALGIA; ARTICLE; DUPUYTREN CONTRACTURE; HUMAN; JOINT STIFFNESS; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL;

AGE FACTORS; AGED; COHORT STUDIES; DUPUYTREN'S CONTRACTURE; HUMANS; ICELAND; INFLAMMATION; JOINT DISEASES; MALE; MIDDLE AGED; PAIN; PREVALENCE;

EID: 0032860445     PISSN: 03009742     EISSN: None     Source Type: Journal    
DOI: 10.1080/03009749950155481     Document Type: Article

References (36)

1. Dupuytren G. Permanent retraction of the fingers, produced by an affection of the palmar fascia Lancet 1834;ii:222-5.
2. Sanderson PL, Morris MA, Stanley JK, Fahmy NR. Lipids and Dupuytren's disease. J Bone Joint Surg 1992;74B:923-7.
3. Burge P, Hoy G, Regan P, Milne R Smoking, alcohol and the risk of Dupuytren's contracture. J Bone Joint Surg 1997;79B:206-10.
4. Liss GM, Stock SR. Can Dupuytren's contracture be work related? review of the evidence. Am J Ind Med 1996;29:521-32.
5. Neumuller J, Menzel J, Millesi H. Prevalence of HLA-DR3 and autoantibodies to connective tissue components in Dupuytren's contracture. Clin Immunol Immunopathol 1994;71:142-8.
6. Jozsa L, Daniel S, Pinter T, et al. Immunopathological study on palmar aponeurosis in Dupuytren's disease. Acta Histochem 1988;83:153-8.
7. Baird KS, Alwan WH, Crossan JF, Wojciak B. T-cell mediated response in Dupuytren's disease. Lancet 1993;341: 1622-3.
8. Pentland AP, Anderson TF. Plantar fibromatosis responds to intralesional steroids. J Am Acad Dermatol 1985;12: 212-4.
9. Shelley WB, Shelley ED. Response of Dupuytren's contracture to high-potency topical steroids. Lancet 1993;342:366.
10. Pittet B, Rubbia-Brandt L, Desmouliere A, et al. Effect of gamma-interferon on the clinical and biologic evolution of hypertrophic scars and Dupuytren's disease: an open pilot study. Plast Reconstr Surg 1994;93:1224-35.
11. Heathcote JG, Cohen M, Noble J. Dupuytren's disease and diabetes mellitus. Lancet 1981;1:1420.
12. Ravid M, Dinai Y, Sohar E. Dupuytren's disease in diabetes mellitus. Acta Diabetol 1977;14:170-4.
13. Arafa M, Steingold RF, Noble J. The incidence of Dupuytren's disease in patients with rheumatoid arthritis. J Hand Surg 1984;9B:165-6.
14. Thorsteinsson J, Björnsson OJ, Kolbeinsson A, Allander E, Sigfússon N, Ólafsson Ó. A population study of rheumatoid factor in Iceland. Ann Clin Res 1975;7:183-94.
15. Jónsson T, Thorsteinsson J, Kolbeinsson A, Jónasdóttir E, Sigfússon N, Valdimarsson H. Population study of the importance of rheumatoid factor isotypes in adults. Ann Rheum Dis 1992;52:863-8.
16. Waaler E. On the occurrence of a factor in human serum activating the specific agglutination of sheep blood corpuscles. Acta Pathol Microbiol Scand 1940;17:172-88.
17. Rose HM, Ragan C, Pearce E, Lipman MO. Differential agglutination of normal and sensitized sheep erythrocytes by sera of patients with rheumatoid arthritis. Proc Soc Exp Biol Med 1948;68:1-6.
18. Rompel R, Mueller-Eckhardt G, Schroeder-Printzen I, Weidner W. HLA antigens in Peyronic's disease. Urol Int 1994;52:34-7.
19. Manson JS. Heredity and Dupuytren's contracture. Br Med J 1931;2:11.
20. Ranta H, Knif J, Ranta K. Familial hypodontia associated with Dupuytren's disease. Scand J Dent Res 1990;98:457-60.
21. Rayan GM. Rheumatoid arthritis and Dupuytren's contracture. Plast Reconstr Surg 1988;81:50-3.
22. Gordon S. Dupuytren's contracture. The significance of various factors in its etiology. Ann Surg 1954;5:683-6.
23. Yost J, Winters T, Fett HC. Dupuytren's contracture: a statistical study. Am J Surg 1955;90:568-71.
24. Hueston JT. The incidence of Dupuytren's contracture. Med J Aust 1960;2:999-1002.
25. Hueston JT. Further studies on the incidence of Dupuytren's contracture. Med J Aust 1962;1:586-8.
26. Early P. Population study in Dupuytren's contracture. J Bone Joint Surg 1962;44:602-13.
27. Mikkelsen OA. The prevalence of Dupuytren's disease in Norway. Acta Chir Stand 1972;138:695-700.
28. Thomas PR, Clarke D. Vibration white finger and Dupuytren's contracture: are they related. Occup Med 1992;42: 155-8.
29. Bergenudd H, Lindgerde F, Nilsson BE. Prevalence of Dupuytren's contracture and its correlation with degenerative changes of the hand and Feet and with criteria of general health. J Hand Surg 1993;18B:254-7.
30. Lennox IA, Murali SR, Porter R. A study of the repeatability of the diagnosis of Dupuytren's contracture and its prevalence in the Grampian Region. J Hand Surg 1993;18B:258-61.
31. Carson J, Clarke C. Dupuytren's contracture in pensioners at the Royal Hospital Chelsea. J R Coll Physicians Lond 1993;27:25-7.
32. Hardy RR, Hayakawa K, Shimizu M, Yamasaki K. Kishimoto T. Rheumatoid factor secretion from human Leu-1 + B cells. Science 1987;236:81-3.
33. Casali P, Notkins AL. CD5+ B lymphocytes, polyreactive antibodies and the human B-cell repertoire, Immunol Today 1989;10:364-8.
34. Youinou P, Mackenzie L, Katsikis P, et al. The relationship between CD5-expressing B lymphocytes and serologic abnormalities in rheumatoid arthritis patients and their relatives. Arthritis Rheum 1990;33:339-48.
35. Arinbjarnarson S, Jónsson T, Steinsson K, et al. IgA rheumatoid factor correlates with changes in B and T lymphocyte subsets and disease manifestations in rheumatoid arthritis. J Rheumatol 1997;24:269-74.
36. Guomundsson KG, Arnmgrimsson R, Arinbjarnarson S, Ólafsson A, Jónsson T. T-and B-lymphocyte subsets in patients with Dupuytren's disease Correlations with disease severity. J Hand Surg 1998;23B:724-7.